日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study

培非替尼治疗中重度类风湿性关节炎的两年安全性和有效性:一项 IIb 期开放标签扩展研究

Genovese, Mark C; Greenwald, Maria W; Gutierrez-Ureña, Sergio R; Cardiel, Mario H; Poiley, Jeffrey E; Zubrzycka-Sienkiewicz, Anna; Codding, Christine E; Wang, Annie; He, Weizhong; Amos, Rebecca; Vinueza, Raul; Wang, Xuegong; Garg, Jay P; Kivitz, Alan J

A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout

一项随机、双盲、活性药物和安慰剂对照的阿洛芬酸酯治疗痛风患者减少痛风发作的疗效和安全性研究

Poiley, Jeffrey; Steinberg, Alexandra S; Choi, Yun-Jung; Davis, Charles S; Martin, Robert L; McWherter, Charles A; Boudes, Pol F